Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 33, 2020 - Issue 4
95
Views
3
CrossRef citations to date
0
Altmetric
Case Studies

Adult Langerhans cell histiocytosis of the central nervous system

, MDORCID Icon, , MDORCID Icon, , MDORCID Icon, , MDORCID Icon & , MD
Pages 603-605 | Received 14 Apr 2020, Accepted 14 May 2020, Published online: 23 Jun 2020

  • Allen CE , Merad M , McClain KL. Langerhans cell histiocytosis. N Engl J Med . 2018;379(9):856–868. doi:10.1056/NEJMra1607548.
  • Mizumoto N , Takashima A. CD1a and Langerin: acting as more than Langerhans cell markers. J Clin Invest . 2004;113(5):658–660. doi:10.1172/JCI21140.
  • Goyal G , Shah MV , Hook CC , et al. Adult disseminated Langerhans cell histiocytosis: incidence, racial disparities and long-term outcomes. Br J Haematol . 2018;182(4):579–581. doi:10.1111/bjh.14818.
  • Badalian-Very G , Vergilio JA , Degar BA , et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood . 2010;116(11):1919–1923. doi:10.1182/blood-2010-04-279083.
  • Arico M , Girschikofsky M , Genereau T , et al. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer . 2003;39(16):2341–2348. doi:10.1016/s0959-8049(03)00672-5.
  • Grois N , Fahrner B , Arceci RJ , et al. Central nervous system disease in Langerhans cell histiocytosis. J Pediatr . 2010;156(6):873–881. doi:10.1016/j.jpeds.2010.03.001.
  • Van't Hooft I , Gavhed D , Laurencikas E , Henter J-I. Neuropsychological sequelae in patients with neurodegenerative Langerhans cell histiocytosis. Pediatr Blood Cancer . 2008;51(5):669–674. doi:10.1002/pbc.21656.
  • Saleem SN , Said AH , Lee DH. Lesions of the hypothalamus: MR imaging diagnostic features. Radiographics . 2007;27(4):1087–1108. doi:10.1148/rg.274065123.
  • McClain KL , Picarsic J , Chakraborty R , et al. CNS Langerhans cell histiocytosis: common hematopoietic origin for LCH-associated neurodegeneration and mass lesions. Cancer . 2018;124(12):2607–2620. doi:10.1002/cncr.31348.
  • Gavhed D , Laurencikas E , Akefeldt SO , Henter JI. Fifteen years of treatment with intravenous immunoglobulin in central nervous system Langerhans cell histiocytosis. Acta Paediatr . 2011;100(7):e36–39. doi:10.1111/j.1651-2227.2010.02125.x.
  • Morimoto A , Oh Y , Shioda Y , Kudo K , Imamura T. Recent advances in Langerhans cell histiocytosis. Pediatr Int . 2014;56(4):451–461. doi:10.1111/ped.12380.
  • Diamond EL , Durham BH , Ulaner GA , et al. Efficacy of MEK inhibition in patients with histiocytic neoplasms. Nature . 2019;567(7749):521–524. doi:10.1038/s41586-019-1012-y.
  • Allen CE , Flores R , Rauch R , et al. Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside. Pediatr Blood Cancer . 2010;54(3):416–423. doi:10.1002/pbc.22326.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.